$BIIB Recent Headlines
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - Russ Britt
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Biogen Idec investors focus on positive, ignore outlook for 2014 2:02 p.m. Jan. 29, 2014 - Russ Britt
Biogen profit jumps on MS treatment revenue 7:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 8:01 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 3:55 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:23 p.m. Jan. 14, 2014 - Sue Chang
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Biogen, Sangamo partner on hemoglobin therapies 9:39 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:29 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:33 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:19 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:56 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Saumya Vaishampayan
Dendreon Corp. (DNDN) Soars: Stock Rises 14.9% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Merrill Lynch’s Top Health Care Stocks to Buy Now 8:04 a.m. Today - 247WallSt.com
Glaxo/Ligand Look to Expand Promacta Label - Analyst Blog 6:15 p.m. March 3, 2014 - Zacks.com
Biogen Idec Keeps Momentum Going With MS Drug Tecfidera 1:05 p.m. March 3, 2014 - Investors Business Daily
First Week Of BIIB October 18th Options Trading 11:04 a.m. March 3, 2014 - TheStreet.com
Transition Therapeutics (TTHI) Jumps: Stock Moves 7.6% Higher - Tale of the Tape 9:46 a.m. March 3, 2014 - Zacks.com
Biogen Idec Inc's Buy Recommendation Affirmed 9:00 a.m. March 3, 2014 - TheStreet.com
Biotech Sector Performance February 2014: Red Hot But... 12:01 p.m. March 1, 2014 - TheStreet.com
Halozyme's Q4 Loss Wider-Than-Expected - Analyst Blog 2:43 p.m. Feb. 28, 2014 - Zacks.com
Idenix Q4 Loss Narrower-Than-Expected - Analyst Blog 2:39 p.m. Feb. 28, 2014 - Zacks.com
Medivation Swings to Earnings in Q4 - Analyst Blog 9:30 a.m. Feb. 28, 2014 - Zacks.com
Zacks Rank #1 Additions for Friday - Tale of the Tape 9:30 a.m. Feb. 28, 2014 - Zacks.com
Mylan, Inc. (MYL) in Focus: Stock up 9.43% - Tale of the Tape 8:44 a.m. Feb. 28, 2014 - Zacks.com
UCB Misses Earnings Ests, Revs In Line - Analyst Blog 1:32 p.m. Feb. 27, 2014 - Zacks.com
Shares Fall as Aegerion Posts Wider-than-Expected Loss - Analyst Blog 1:26 p.m. Feb. 27, 2014 - Zacks.com
Dyax Corp. (DYAX) Soars: Stock Rises 6.7% - Tale of the Tape 9:39 a.m. Feb. 27, 2014 - Zacks.com
Aegerion (AEGR) Falls: Stock Loses 7.3% - Tale of the Tape 8:42 a.m. Feb. 27, 2014 - Zacks.com
Short Sellers Return to Biotech Stocks 6:56 a.m. Feb. 27, 2014 - 247WallSt.com
You’re Way Too Late for These 2 Sector Parties 3:08 a.m. Feb. 27, 2014 - InvestorPlace.com
InterMune Soars on Positive Esbriet Data - Analyst Blog 4:45 p.m. Feb. 26, 2014 - Zacks.com
Global Biosimilars Market 2014-2018 10:28 a.m. Feb. 27, 2014 - PR Newswire - PRF
Critical Alerts For Walter Energy, Regeneron, Biogen Idec, Red Hat, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. Feb. 27, 2014 - PR Newswire - PRF
WuXi PharmaTech Announces Appointment of Dr. Hua Mu to Head Product Development Service and Partnership Business Unit 9:33 a.m. Feb. 26, 2014 - PR Newswire - PRF
RBCC Increases Foothold in 3D Bioprinting Market 7:49 a.m. Feb. 26, 2014 - BusinessWire - BZX
Biogen Idec to Present at the Cowen & Company 34th Annual Health Care Conference 4:01 p.m. Feb. 25, 2014 - BusinessWire - BZX
SciQuest Customers to Discuss Procurement Transformation in Action at NextLevel 2014 8:35 a.m. Feb. 24, 2014 - BusinessWire - BZX
RBCC: New Innovations Spur Demand for 3D Printing in Medicine 5:00 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 2014 RBC Capital Markets’ Healthcare Conference 4:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
New Product Puts RBCC on Leading Edge of Organ Regeneration Research 5:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
William D. Young To Retire From Biogen Idec’s Board of Directors 1:50 p.m. Feb. 15, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion 5:00 a.m. Feb. 6, 2014 - BusinessWire - BZX
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 9:33 a.m. Feb. 3, 2014 - BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 8:53 a.m. Feb. 3, 2014 - BusinessWire - BZX
RBCC: 3D Bioprinting Tech Ushers in Future of Medicine 8:40 a.m. Feb. 3, 2014 - BusinessWire - BZX
Ignyta Appoints Matthew Onaitis as General Counsel 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Biogen Idec Foundation Awards Museum of Science $2.5 Million to Support Hall of Human Life 8:30 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia 1:00 a.m. Jan. 30, 2014 - BusinessWire - BZX
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - Russ Britt
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Biogen Idec investors focus on positive, ignore outlook for 2014 2:02 p.m. Jan. 29, 2014 - Russ Britt
Biogen profit jumps on MS treatment revenue 7:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 8:01 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 3:55 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:23 p.m. Jan. 14, 2014 - Sue Chang
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Biogen, Sangamo partner on hemoglobin therapies 9:39 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:29 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:33 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:19 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:56 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Saumya Vaishampayan
Dendreon Corp. (DNDN) Soars: Stock Rises 14.9% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Merrill Lynch’s Top Health Care Stocks to Buy Now 8:04 a.m. Today - 247WallSt.com
Glaxo/Ligand Look to Expand Promacta Label - Analyst Blog 6:15 p.m. March 3, 2014 - Zacks.com
Biogen Idec Keeps Momentum Going With MS Drug Tecfidera 1:05 p.m. March 3, 2014 - Investors Business Daily
First Week Of BIIB October 18th Options Trading 11:04 a.m. March 3, 2014 - TheStreet.com
Transition Therapeutics (TTHI) Jumps: Stock Moves 7.6% Higher - Tale of the Tape 9:46 a.m. March 3, 2014 - Zacks.com
Biogen Idec Inc's Buy Recommendation Affirmed 9:00 a.m. March 3, 2014 - TheStreet.com
Biotech Sector Performance February 2014: Red Hot But... 12:01 p.m. March 1, 2014 - TheStreet.com
Halozyme's Q4 Loss Wider-Than-Expected - Analyst Blog 2:43 p.m. Feb. 28, 2014 - Zacks.com
Idenix Q4 Loss Narrower-Than-Expected - Analyst Blog 2:39 p.m. Feb. 28, 2014 - Zacks.com
Medivation Swings to Earnings in Q4 - Analyst Blog 9:30 a.m. Feb. 28, 2014 - Zacks.com
Zacks Rank #1 Additions for Friday - Tale of the Tape 9:30 a.m. Feb. 28, 2014 - Zacks.com
Mylan, Inc. (MYL) in Focus: Stock up 9.43% - Tale of the Tape 8:44 a.m. Feb. 28, 2014 - Zacks.com
UCB Misses Earnings Ests, Revs In Line - Analyst Blog 1:32 p.m. Feb. 27, 2014 - Zacks.com
Shares Fall as Aegerion Posts Wider-than-Expected Loss - Analyst Blog 1:26 p.m. Feb. 27, 2014 - Zacks.com
Dyax Corp. (DYAX) Soars: Stock Rises 6.7% - Tale of the Tape 9:39 a.m. Feb. 27, 2014 - Zacks.com
Aegerion (AEGR) Falls: Stock Loses 7.3% - Tale of the Tape 8:42 a.m. Feb. 27, 2014 - Zacks.com
Short Sellers Return to Biotech Stocks 6:56 a.m. Feb. 27, 2014 - 247WallSt.com
You’re Way Too Late for These 2 Sector Parties 3:08 a.m. Feb. 27, 2014 - InvestorPlace.com
InterMune Soars on Positive Esbriet Data - Analyst Blog 4:45 p.m. Feb. 26, 2014 - Zacks.com
Global Biosimilars Market 2014-2018 10:28 a.m. Feb. 27, 2014 - PR Newswire - PRF
Critical Alerts For Walter Energy, Regeneron, Biogen Idec, Red Hat, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. Feb. 27, 2014 - PR Newswire - PRF
WuXi PharmaTech Announces Appointment of Dr. Hua Mu to Head Product Development Service and Partnership Business Unit 9:33 a.m. Feb. 26, 2014 - PR Newswire - PRF
RBCC Increases Foothold in 3D Bioprinting Market 7:49 a.m. Feb. 26, 2014 - BusinessWire - BZX
Biogen Idec to Present at the Cowen & Company 34th Annual Health Care Conference 4:01 p.m. Feb. 25, 2014 - BusinessWire - BZX
SciQuest Customers to Discuss Procurement Transformation in Action at NextLevel 2014 8:35 a.m. Feb. 24, 2014 - BusinessWire - BZX
RBCC: New Innovations Spur Demand for 3D Printing in Medicine 5:00 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 2014 RBC Capital Markets’ Healthcare Conference 4:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
New Product Puts RBCC on Leading Edge of Organ Regeneration Research 5:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
William D. Young To Retire From Biogen Idec’s Board of Directors 1:50 p.m. Feb. 15, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion 5:00 a.m. Feb. 6, 2014 - BusinessWire - BZX
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 9:33 a.m. Feb. 3, 2014 - BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 8:53 a.m. Feb. 3, 2014 - BusinessWire - BZX
RBCC: 3D Bioprinting Tech Ushers in Future of Medicine 8:40 a.m. Feb. 3, 2014 - BusinessWire - BZX
Ignyta Appoints Matthew Onaitis as General Counsel 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Biogen Idec Foundation Awards Museum of Science $2.5 Million to Support Hall of Human Life 8:30 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia 1:00 a.m. Jan. 30, 2014 - BusinessWire - BZX
